All Stories

  1. A Review of Preclinical Tools to Validate Anti-Diarrheal Agents

    Article • Current Reviews in Clinical and Experimental Pharmacology, March 2024, Bentham Science Publishers

    Mr. ANSHUL SHAKYA, Prof Hans Raj Bhat, Rajdeep Sarma

  2. Hybrid PABA‐glutamic acid conjugated 1,3,5‐triazine derivatives: Design, synthesis, and antimalarial activity screening targeting Plasmodium falciparum dihydro folate reductase enzyme

    Article • Chemical Biology & Drug Design, October 2023, Wiley

    Prof Hans Raj Bhat

  3. Discovery of novel 1,3,5-triazine derivatives as an antidiabetic agent in Wistar rats via inhibition of DPP-4

    Article • Future Medicinal Chemistry, May 2023, Future Science

    Prof Hans Raj Bhat

  4. Aminoquinoline-triazine Conjugates: Design, Synthesis, Antibacterial Activity, and SAR Analysis

    Article • Letters in Drug Design & Discovery, March 2023, Bentham Science Publishers

    Mr. ANSHUL SHAKYA, Uday Singh, Prof Hans Raj Bhat

  5. Discovery of imeglimin-inspired novel 1,3,5-triazine derivatives as antidiabetic agents in streptozotocin-induced diabetes in Wistar rats via inhibition of DPP-4

    Article • RSC Medicinal Chemistry, January 2023, Royal Society of Chemistry

    Prof Hans Raj Bhat

  6. Design and development of novel N‐(4‐aminobenzoyl)‐l‐glutamic acid conjugated 1,3,5‐triazine derivatives as Pf‐DHFR inhibitor: An in‐silico and in‐vitro study

    Article • Journal of Biochemical and Molecular Toxicology, December 2022, Wiley

    Prof Hans Raj Bhat

  7. Molecular docking and antimalarial evaluation of novel N-(4-aminobenzoyl)-l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitors

    Article • 3 Biotech, November 2022, Springer Science + Business Media

    Prof Hans Raj Bhat

  8. Implicit, Intrinsic, Extrinsic, and Host Factors Attributing the COVID-19 Pandemic. Part 3- Host Factor GDP: A Systematic Analysis

    Article • April 2022, Research Square

    Prof Hans Raj Bhat

  9. Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2

    Article • Archiv der Pharmazie, March 2022, Wiley

    Prof Hans Raj Bhat

  10. Investigation of Oral Subacute Toxicity and In-Vitro Antioxidant Activity of Standardized Methanolic Extract of Quercus serrata Leaves

    Article • Current Bioactive Compounds, November 2021, Bentham Science Publishers

    Mr. ANSHUL SHAKYA, Maibam Beebina Chanu, Prof Hans Raj Bhat

  11. An Overview of Phytochemical and Pharmacological Profile of Morus alba Linn

    Article • Current Bioactive Compounds, October 2021, Bentham Science Publishers

    Mr. ANSHUL SHAKYA, MS. Arpita Paul, Md Kamaruz Zaman, Prof Hans Raj Bhat

  12. Microwave‐assisted synthesis of hybrid PABA‐1,3,5‐triazine derivatives as an antimalarial agent

    Article • Journal of Biochemical and Molecular Toxicology, July 2021, Wiley

    Prof Hans Raj Bhat

  13. 1,3,5‐Triazine: A versatile pharmacophore with diverse biological activities

    Article • Archiv der Pharmazie, March 2021, Wiley

    Saumya Singh, Prof Hans Raj Bhat

  14. In silico study, synthesis, and evaluation of the antimalarial activity of hybrid dimethoxy pyrazole 1,3,5‐triazine derivatives

    Article • Journal of Biochemical and Molecular Toxicology, December 2020, Wiley

    Prof Hans Raj Bhat

  15. Discovery of novel 1,3,5‐triazine as adenosine A2A receptor antagonist for benefit in Parkinson's disease

    Article • Journal of Biochemical and Molecular Toxicology, November 2020, Wiley

    Prof Hans Raj Bhat

  16. Discovery of novel pyrazole derivatives as a potent anti‐inflammatory agent in RAW264.7 cells via inhibition of NF‐ĸB for possible benefit against SARS‐CoV‐2

    Article • Journal of Biochemical and Molecular Toxicology, October 2020, Wiley

    Prof Hans Raj Bhat

  17. Docking, Synthesis and Antimalarial Evaluation of Hybrid Phenyl Thiazole 1,3,5-Triazine Derivatives

    Article • Current Bioactive Compounds, July 2020, Bentham Science Publishers

    Nayana Adhikari, Prof Hans Raj Bhat

  18. A Review of Phytochemical and Pharmacological Studies of Inula Species

    Article • Current Bioactive Compounds, July 2020, Bentham Science Publishers

    Dr Aparoop Das, Mr. ANSHUL SHAKYA, Prof Hans Raj Bhat

  19. Potent antibacterial activity of dihydydropyrimidine‐1,3,5‐triazines via inhibition of DNA gyrase and antifungal activity with favourable metabolic profile

    Article • Chemical Biology & Drug Design, May 2020, Wiley

    Prof Hans Raj Bhat

  20. Microwave assisted synthesis, docking and antimalarial evaluation of hybrid PABA‐substituted 1,3,5‐triazine derivatives

    Article • Journal of Heterocyclic Chemistry, March 2020, Wiley

    Nayana Adhikari, Mr. ANSHUL SHAKYA, Prof Hans Raj Bhat

  21. A Comprehensive Review on Preclinical Diabetic Models

    Article • Current Diabetes Reviews, January 2020, Bentham Science Publishers

    Mr. ANSHUL SHAKYA, Prof Hans Raj Bhat

  22. Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4‐aminoquinoline‐1,3,5‐triazine derivatives

    Article • Journal of Heterocyclic Chemistry, December 2019, Wiley

    Mr. ANSHUL SHAKYA, Prof Hans Raj Bhat

  23. Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives

    Article • Arabian Journal of Chemistry, September 2016, Elsevier

    Dr Aparoop Das, Prof Hans Raj Bhat

  24. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS

    Article • Experimental Parasitology, April 2016, Elsevier

    Prof Hans Raj Bhat

  25. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives

    Article • Experimental Parasitology, October 2015, Elsevier

    Prof Hans Raj Bhat

  26. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4‐aminoquinoline–1,3,5‐triazine Derivatives Against Wild and Mutant Malaria Parasites

    Article • Chemical Biology & Drug Design, January 2015, Wiley

    Prof Hans Raj Bhat

  27. Discovery of novel 1,3,5-triazine-thiazolidine-2,4-diones as dipeptidyl peptidase-4 inhibitors with antibacterial activity targeting the S1 pocket for the treatment of type 2 diabetes

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Prof Hans Raj Bhat

  28. Pharmacological evaluation of hybrid thiazolidin-4-one-1,3,5-triazines for NF-κB, biofilm and CFTR activity

    Article • RSC Advances, January 2015, Royal Society of Chemistry

    Uday Singh, Prof Hans Raj Bhat

  29. Structure-guided discovery of 1,3,5-triazine–pyrazole conjugates as antibacterial and antibiofilm agent against pathogens causing human diseases with favorable metabolic fate

    Article • Bioorganic & Medicinal Chemistry Letters, August 2014, Elsevier

    Prof Hans Raj Bhat

  30. Hybrid 4-Aminoquinoline-1,3,5-triazine Derivatives: Design, Synthesis, Characterization, and Antibacterial Evaluation

    Article • Journal of Heterocyclic Chemistry, June 2014, Wiley

    Prof Hans Raj Bhat

  31. Utilisation of Home Laundry Effluent (HLE) as a catalyst for expeditious one-pot aqueous phase synthesis of highly functionalised 4-thiazolidinones

    Article • SpringerPlus, September 2013, Springer Science + Business Media

    Prof Hans Raj Bhat

  32. Ceric ammonium nitrate (CAN) catalysed expeditious one-pot synthesis of 1,3-thiazine as IspE kinase inhibitor of Gram-negative bacteria using polyethylene glycol (PEG-400) as an efficient recyclable reaction medium

    Article • Comptes Rendus Chimie, May 2013, Cellule MathDoc/CEDRAM

    Prof Hans Raj Bhat

  33. Development of 4-aminoquinoline-1,3,5-triazine conjugates as potent antibacterial agent through facile synthetic route

    Article • Medicinal Chemistry Research, February 2013, Springer Science + Business Media

    Prof Hans Raj Bhat

  34. 4-Aminoquinoline-1,3,5-triazine: Design, synthesis, in vitro antimalarial activity and docking studies

    Article • New Journal of Chemistry, January 2013, Royal Society of Chemistry

    Prof Hans Raj Bhat

  35. Phenyl hydrazone bearing pyrazole and pyrimidine scaffolds: design and discovery of a novel class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) against HIV-1 and their antibacterial properties

    Article • RSC Advances, January 2013, Royal Society of Chemistry

    Ramendra K Singh, Prof Hans Raj Bhat

  36. Antimalarial activity and docking studies of novel bi-functional hybrids derived from 4-aminoquinoline and 1,3,5-triazine against wild and mutant malaria parasites as pf-DHFR inhibitor

    Article • RSC Advances, January 2013, Royal Society of Chemistry

    Prof Hans Raj Bhat

  37. Design and one-pot synthesis of hybrid thiazolidin-4-one-1,3,5-triazines as potent antibacterial agents against human disease-causing pathogens

    Article • New Journal of Chemistry, January 2013, Royal Society of Chemistry

    Prof Hans Raj Bhat

  38. Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol

    Article • Saudi Pharmaceutical Journal, January 2013, Elsevier

    Prof Hans Raj Bhat

  39. Design, Facile Synthesis, and Antibacterial Activity of Hybrid 1,3,4‐thiadiazole‐1,3,5‐triazine Derivatives Tethered via –S– Bridge

    Article • Chemical Biology & Drug Design, July 2012, Wiley

    Uday Singh, Prof Hans Raj Bhat

  40. Design, Synthesis, Antibacterial Activity, and Molecular Docking Studies of Novel Hybrid 1,3‐Thiazine‐1,3,5‐Triazine Derivatives as Potential Bacterial Translation Inhibitor

    Article • Chemical Biology & Drug Design, July 2012, Wiley

    Prof Hans Raj Bhat

  41. Antifungal activity, SAR and physicochemical correlation of some thiazole-1,3,5-triazine derivatives

    Article • Journal de Mycologie Médicale, June 2012, Elsevier

    Prof Hans Raj Bhat

  42. In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives

    Article • Letters in Applied Microbiology, March 2012, Oxford University Press (OUP)

    Prof Hans Raj Bhat

  43. Design, Facile Synthesis, Antibacterial Activity and Structure-Activity Relationship of Novel Di- and Tri-Substituted 1,3,5-Triazines

    Article • Letters in Drug Design & Discovery, March 2012, Bentham Science Publishers

    Prof Hans Raj Bhat

  44. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition

    Article • Experimental Parasitology, March 2012, Elsevier

    Mr Pratap Parida, Mr Pratap Parida, Prof Hans Raj Bhat

  45. Synthesis, SAR and antibacterial activity of hybrid chloro, dichloro-phenylthiazolyl-s-triazines

    Article • Saudi Pharmaceutical Journal, January 2012, Elsevier

    Prof Hans Raj Bhat

  46. Discovery of potent, novel antibacterial hybrid conjugates from 4-aminoquinoline and 1,3,5-triazine: design, synthesis and antibacterial evaluation

    Article • RSC Advances, January 2012, Royal Society of Chemistry

    Prof Hans Raj Bhat

  47. Synthesis and antibacterial evaluation of series of novel tri-substituted-s-triazine derivatives

    Article • Medicinal Chemistry Research, September 2010, Springer Science + Business Media

    Prof Hans Raj Bhat